180 related articles for article (PubMed ID: 37045732)
1. [Second allogeneic (update). Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Yafour N; Couturier MA; Borel C; Charbonnier A; Coman T; Fayard A; Masouridi-Levrat S; Yakoub-Agha I; Roy J
Bull Cancer; 2024 Feb; 111(2S):S29-S39. PubMed ID: 37045732
[TBL] [Abstract][Full Text] [Related]
2. [Preventative and therapeutic relapse strategies after allogeneic hematopoietic stem cell transplantation: Guidelines from the Francophone society of bone marrow transplantation and cellular therapy (SFGM-TC)].
Yafour N; Beckerich F; Bulabois CE; Chevallier P; Daguindau É; Dumesnil C; Guillaume T; Huynh A; Levrat SM; Menard AL; Michallet M; Pautas C; Poiré X; Ravinet A; Yakoub-Agha I; Bazarbachi A
Bull Cancer; 2017 Dec; 104(12S):S84-S98. PubMed ID: 29179894
[TBL] [Abstract][Full Text] [Related]
3. [Acute lymphoblastic leukemia in developing countries: Management from the transplant indication (allo/auto) until post-transplant follow-up. Guidelines from the SFGM-TC].
Yafour N; Hamzy F; Elkababri M; Yakoub-Agha I; Bekadja MA
Bull Cancer; 2023 Feb; 110(2S):S30-S38. PubMed ID: 35562231
[TBL] [Abstract][Full Text] [Related]
4. [Second allogeneic hematopoietic stem cell transplant: Guidelines from the francophone Society of bone marrow transplantation and cellular therapy (SFGM-TC)].
Yafour N; Couturier MA; Azarnoush S; Girault S; Hermet E; Masouridi Levrat S; Schmidt A; Michallet M; Etancelin P; Guillaume T; Malard F; Sirvent A; Yakoub-Agha I; Poiré X
Bull Cancer; 2019 Jan; 106(1S):S40-S51. PubMed ID: 30409466
[TBL] [Abstract][Full Text] [Related]
5. [Vaccination of allogeneic haematopoietic stem cell transplant recipients: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Conrad A; Beguin Y; Guenounou S; Le Bourgeois A; Ménard AL; Rialland F; Layal S; Mamez AC; Yakoub-Agha I; El Cheikh J
Bull Cancer; 2024 Feb; 111(2S):S40-S49. PubMed ID: 37479644
[TBL] [Abstract][Full Text] [Related]
6. [Role of allogeneic hematopoietic cell transplantation after anti-CD19 CAR T-cell treatment: Guidelines from the SFGM-TC].
Beauvais D; Castilla-Llorente C; Diral E; Sirvent A; Vandewiele A; Baruchel A; Yakoub-Agha I; Yakouben K
Bull Cancer; 2023 Feb; 110(2S):S108-S115. PubMed ID: 35791974
[TBL] [Abstract][Full Text] [Related]
7. [Secondary cancers following allogeneic hematopoietic stem cell transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Loschi M; Alsuliman T; Cabrera Q; Desbrosses Y; Desmier D; Yakoub Agha I; Guillaume T
Bull Cancer; 2024 Feb; 111(2S):S22-S28. PubMed ID: 36922321
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors of second hematopoietic allogeneic stem cell transplantation among hematological malignancy patients relapsed after first hematopoietic stem cell transplantation: A single center study.
Lu Y; Zhang JP; Zhao YL; Xiong M; Sun RJ; Cao XY; Wei ZJ; Zhou JR; Liu DY; Yang JF; Zhang X; Lu DP; Lu P
Front Immunol; 2022; 13():1066748. PubMed ID: 36685540
[TBL] [Abstract][Full Text] [Related]
9. [Use of alternative donors for allogeneic haematopoietic cell transplantation in lymphoid neoplasms: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Gauthier J; Chantepie S; Bouabdallah K; Jost E; Nguyen S; Gac AC; Damaj G; Duléry R; Michallet M; Delage J; Lewalle P; Morschhauser F; Salles G; Yakoub-Agha I; Cornillon J
Bull Cancer; 2017 Dec; 104(12S):S106-S111. PubMed ID: 29169650
[TBL] [Abstract][Full Text] [Related]
10. [Haemorrhagic cystitis following hematopoietic stem cell transplantation: Prophylaxis, diagnosis, and treatment. Guidelines from the SFGM-TC].
Dequirez PL; Magro L; Alsuliman T; Ceballos P; Desbrosses Y; Yakoub-Agha I; Guillaume T
Bull Cancer; 2023 Feb; 110(2S):S48-S55. PubMed ID: 35181061
[TBL] [Abstract][Full Text] [Related]
11. [Hepatobiliary complications following allogeneic hematopoietic cell transplantation: Recommendations of the Francophone Society of Bone Marrow transplantation and cellular Therapy (SFGM-TC)].
Detrait M; de Berranger E; Dulery R; Ménard AL; Thépot S; Toprak SK; Turlure P; Yakoub-Agha I; Guillaume T
Bull Cancer; 2020 Jan; 107(1S):S18-S27. PubMed ID: 30952358
[TBL] [Abstract][Full Text] [Related]
12. [Second allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning and donor changes in relapsed hematological malignancies after the first allogeneic transplant].
Zhao YQ; Song YZ; Li ZH; Yang F; Xu T; Li FF; Yang DF; Wu T
Zhonghua Xue Ye Xue Za Zhi; 2023 Jun; 44(6):465-471. PubMed ID: 37550201
[No Abstract] [Full Text] [Related]
13. [Mobilization and conditioning protocols actualization for autologous stem cell transplantation for autoimmune diseases: Guidelines from MATHEC-SFGM-TC].
Bonnin A; Terriou L; Beuvon C; Tudesq JJ; Puyade M; Pugnet G; Maria A; Llorente CC; Lansiaux P; Cacciatore C; Badoglio M; Yakoub-Agha I; Farge-Bancel D; Marjanovic Z
Bull Cancer; 2024 Feb; 111(2S):S84-S95. PubMed ID: 37845095
[TBL] [Abstract][Full Text] [Related]
14. [Allogeneic hematopoietic stem cell transplantation and treatment with CAR-T cells - identification of psycho-social vulnerability factors: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Polomeni A; Ainaoui M; Berr A; de Bentzman N; Denis M; Friser V; Magro L; Yakoub-Agha I
Bull Cancer; 2024 Feb; 111(2S):S67-S77. PubMed ID: 37169605
[TBL] [Abstract][Full Text] [Related]
15. [Unrelated donor selection for allogeneic hematopoietic stem cell transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Cornillon J; Crocchiolo R; Dubois V; Guidicelli G; Jorge-Cordeiro D; Meunier MC; Michiels S; Timmermans A; Villemonteix J; Yakoub-Agha I; Ahmad I
Bull Cancer; 2024 Feb; 111(2S):S1-S13. PubMed ID: 37690877
[TBL] [Abstract][Full Text] [Related]
16. Outcome of Second Allogeneic Hematopoietic Cell Transplantation after Relapse of Myeloid Malignancies following Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort on Behalf of the Grupo Español de Trasplante Hematopoyetico.
Orti G; Sanz J; Bermudez A; Caballero D; Martinez C; Sierra J; Cabrera Marin JR; Espigado I; Solano C; Ferrà C; García-Noblejas A; Jimenez S; Sampol A; Yañez L; García-Gutiérrez V; Pascual MJ; Jurado M; Moraleda JM; Valcarcel D; Sanz MA; Carreras E; Duarte RF
Biol Blood Marrow Transplant; 2016 Mar; 22(3):584-8. PubMed ID: 26631751
[TBL] [Abstract][Full Text] [Related]
17. [Establishment of Hematopoietic cell transplantation program in developing countries : Guidelines from the francophone Society of bone marrow transplantation and cellular therapy (SFGM-TC)].
Yafour N; Bekadja MA; Chevallier P; Cabrera Q; Coman T; Elkababri M; Hamzy F; Quessar A; Laamiri A; Pochon C; Yakoub-Agha I; Harif M
Bull Cancer; 2021 Dec; 108(12S):S10-S19. PubMed ID: 34247762
[TBL] [Abstract][Full Text] [Related]
18. [Renal failure after allogeneic hematopoietic stem cell transplantation: Recommendations of the Francophone Society of Bone Marrow transplantation and cellular Therapy (SFGM-TC)].
Detrait M; de Berranger E; Dulery R; Ménard AL; Thépot S; Toprak SK; Turlure P; Yakoub-Agha I; Guillaume T
Bull Cancer; 2020 Jan; 107(1S):S28-S35. PubMed ID: 31303250
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of a Second Allogeneic Hematopoietic Cell Transplant in Relapsed Acute Myeloid Leukemia: Results of a Systematic Review and Meta-Analysis.
Kharfan-Dabaja MA; Reljic T; Yassine F; Nishihori T; Kumar A; Tawk MM; Keller K; Ayala E; Savani B; Mohty M; Aljurf M; Saber W
Transplant Cell Ther; 2022 Nov; 28(11):767.e1-767.e11. PubMed ID: 35970301
[TBL] [Abstract][Full Text] [Related]
20. [Donor Lymphocyte Infusions (DLI): Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
De Vos J; Baudoux E; Bay JO; Calmels B; Cras A; El Cheikh J; Guerout-Verite MA; Lacassagne MN; Lamure S; Letellier C; Menard AL; Daguindau E; Poiré X; Yakoub-Agha I; Guillaume T
Bull Cancer; 2019 Jan; 106(1S):S35-S39. PubMed ID: 30580911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
